Figure 1.
Preparation and characterization of ATRA-NPs. (a) Preparation and application of ATRA-NPs for inhibiting cancer growth and metastasis. (b) Experimental factors and levels. (c) Optimization analysis of the response of experimental factors. SEM and TEM images for (d) blank NPs and (e) ATRA-NPs. (f) Particle size, (g) DL and (h) EE of ATRA-NPs prepared under optimized experimental condition (n = 4). (i) Drug release of ATRA-NPs in PBS and PBS containing 5% FBS (n = 3).